122 related articles for article (PubMed ID: 6499279)
1. A cutaneous complication of Dorbanex therapy.
Cox NH; Vickers CF
Clin Exp Dermatol; 1984 Nov; 9(6):624-5. PubMed ID: 6499279
[No Abstract] [Full Text] [Related]
2. A cutaneous complication of Dorbanex therapy.
Barth JH; Reshad H; Darley CR; Gibson JR
Clin Exp Dermatol; 1984 Jan; 9(1):95-6. PubMed ID: 6229370
[No Abstract] [Full Text] [Related]
3. Unusual case of skin discoloration.
Darke CS; Cooper RG
Br Med J; 1978 May; 1(6121):1188-9. PubMed ID: 638688
[No Abstract] [Full Text] [Related]
4. Letter: Red skin and dorbanex.
Ippen H
Br Med J; 1974 Nov; 4(5940):345. PubMed ID: 4434104
[No Abstract] [Full Text] [Related]
5. [Perianal toxic contact dermatitis after use of the laxative Dorbantyl].
Hanssen LI; Nyfors A
Tidsskr Nor Laegeforen; 1982 Nov; 102(32):1716. PubMed ID: 7167944
[No Abstract] [Full Text] [Related]
6. Letter: Hazards of multilaxative mixtures.
Godding EW
Br Med J; 1976 Apr; 1(6013):838. PubMed ID: 1260374
[No Abstract] [Full Text] [Related]
7. [Acute skin damage caused by "X-prep"].
Helwig H; Mund H
Monatsschr Kinderheilkd; 1986 Mar; 134(3):164. PubMed ID: 3702887
[No Abstract] [Full Text] [Related]
8. Letter: Red skin and Dorbanex.
Bunney MH; Noble IM
Br Med J; 1974 Jun; 2(5921):731. PubMed ID: 4859393
[No Abstract] [Full Text] [Related]
9. [Perianal skin changes caused by anthraquinone in laxatives].
Bergström G; Holst R
Lakartidningen; 1972 Oct; 69():Suppl 3:28-9. PubMed ID: 4264668
[No Abstract] [Full Text] [Related]
10. Clinical and toxicological aspects of anthraquinone laxatives.
Nelemans FA
Pharmacology; 1976; 14 Suppl 1():73-7. PubMed ID: 981318
[No Abstract] [Full Text] [Related]
11. [Danthron prohibition].
Ippen H
Dtsch Med Wochenschr; 1987 Apr; 112(14):569-70. PubMed ID: 3829944
[No Abstract] [Full Text] [Related]
12. Possible hepatotoxicity of Doxidan.
Tolman KG; Hammar S; Sannella JJ
Ann Intern Med; 1976 Mar; 84(3):290-2. PubMed ID: 1259264
[TBL] [Abstract][Full Text] [Related]
13. Laxative eruption.
Verbov J
Clin Exp Dermatol; 1984 Jul; 9(4):435. PubMed ID: 6235067
[No Abstract] [Full Text] [Related]
14. Acute generalized exanthematous pustulosis caused by sennoside in a patient with multiple myeloma.
Sugita K; Nishio D; Kabashima K; Tokura Y
J Eur Acad Dermatol Venereol; 2008 Apr; 22(4):517-9. PubMed ID: 18363928
[No Abstract] [Full Text] [Related]
15. [Chloasma, a complication of treatments with synthetic progestational hormones (7 cases)].
Thiers H; Villedieu P; Moulin G
J Med Lyon; 1966 Dec; 47(111):1815-6 passim. PubMed ID: 5990283
[No Abstract] [Full Text] [Related]
16. Adverse reaction to X-Prep.
Jagjivan B; Morcos SK; Liddell H
Br J Radiol; 1988 Sep; 61(729):853-4. PubMed ID: 3179647
[No Abstract] [Full Text] [Related]
17. A case of generalized fixed drug eruption due to a piroxicam plaster.
Rho YK; Yoo KH; Kim BJ; Kim MN; Song KY
Clin Exp Dermatol; 2010 Mar; 35(2):204-5. PubMed ID: 20447085
[No Abstract] [Full Text] [Related]
18. Danthron.
National Toxicology Program
Rep Carcinog; 2011; 12():128-9. PubMed ID: 21850139
[No Abstract] [Full Text] [Related]
19. [Colon cleansing: a comparative study].
Ritsema GH
Ned Tijdschr Geneeskd; 1983 Jan; 127(4):144-7. PubMed ID: 6828182
[No Abstract] [Full Text] [Related]
20. Danthron alarm, FDA response: crucial OTC drug control.
Gilbertson WE; Lessing M
Mil Med; 1988 Sep; 153(9):487-8. PubMed ID: 3141843
[No Abstract] [Full Text] [Related]
[Next] [New Search]
